About HEC
Total assets
Listed Companies
Existing staff
Laboratory
+
R & D team
+
Patents
3777金沙娱场城是一个充满希望、专注于实业、正在铸就百年基业的高科技大型股份制企业，现有员工2万余人；主要从事“电子新材料”、“生物医药”和“健康养生”三大行业，现有广东东莞、广东韶关、湖北宜昌、浙江东阳、内蒙古乌兰察布、贵庆、西藏林芝七大基地；已拥有3777金沙娱场城(600673.SH)、3777金沙娱场城药(01558.HK)两家上市公司。
\n","layout_1":[{},{}],"prompt_7":"","status_13":true,"layout_2":[{}],"layout_3":[{}],"href_13":{"type":"link","value":"/development.html?isPreview=true","target":"_blank"},"text_4":"公司简介","text_7":"发展历程","text_6":"了解更多 →","richtext_8":"公司成立于1997年
More than 3,500 patents have been applied, including more than 1,500 foreign patents
HEC Group has made accumulative donations worth over 200 million yuan to the field of social welfare and charity
3777金沙娱场城集团已向社会公益慈善领域累计捐款捐物价值超过2亿人民币
\n\n现有员工2万多人
-
New Electronic Materials
-
Biomedicine Industry
-
Health And Wellness
New Electronic Materials
New electronic materials - The new electronic material industry already owns an A-share listed company HEC (600673.SH); it develops core industries around the capacitor industry chain and battery material industry clusters, and has created four major industry clusters: electronic component, high-end aluminum foil, new chemical material, and new energy material. Relying on the complete industry chain and technological innovation advantages, it actively responds to the national "double carbon" policy, closely focuses on market demand, continuously improves the industrial layout, and strives to build an internationally advanced new energy material platform company within 5-8 years!
Learn mode →
Biomedicine Industry
Biomedicine industry- The biomedical industry mainly includes Sunshine Lake Pharma Co., Ltd. and HEC Pharm Co., Ltd. two business systems. Sunshine Lake Pharma Co., Ltd. includes HEC Pharmaceutical Research Institute, domestic preparation business ("HEC Changjiang Pharmaceutical", which has been listed in Hong Kong stock market) and pharmaceutical business for foreign markets; HEC Pharm Co., Ltd. is mainly engaged in bio-fermentation API.
Learn mode →
Health And Wellness
Health and wellness - HEC Health has a research institute with more than 200 high-end R&D talents, and has built an industrialization base mainly in Yichang, Hubei, supplemented by Shaoguan, Guangdong and Nyingchi, Tibet. In the future, the research and development and production base of Cordyceps sinensis deep processing products will be built in Zhuhai Hengqin and Dongyang, Zhejiang. Adhering to the concepts of safety, health, ecology and high technology, HEC will build a large-scale health industry dominated by Cordyceps sinensis, and continue to develop and innovate ecologically bred Cordyceps sinensis and its deep-processed products, health food, health care products, cosmetics and other large-scale health products cluster.
Learn mode →
R & D Center
In 2005, HEC established the General Research Institute, which consists of three branches: the Pharmaceutical Research Institute, the Great Health Research Institute and the New Energy Research Institute. Through 17 years of unremitting efforts, it has possessed continuous and systematic research and development capabilities. The research and development concept is occidentalized, the scientific research talents are globalized, and the research and development and testing equipment are first-class.
The institute has more than 20 foreign and returnee experts, more than 100 doctors, more than 1,000 masters, more than 1,700 R&D personnel, and has first-class medicinal chemistry capabilities, thus forming a unique R&D model of "domestic elite-led, returnee expert guidance, overseas consultant guidance”.
The institute has applied for more than 3,500 patents, and its foreign patents are more than 1,500; the total number of pharmaceutical patents, compound patents, compound PCT patents, patent application growth rate and patent quality applied by HEC drugs each year rank in the forefront of China.
研究院有20多名外籍和海归专家，100余名博士，1000余名硕士，共有1700余名研发人员，药物化学能力一流，从而形成了特有的“海内精英主导、海归专家指导、海外顾问引导”的研发模式。
\n","richtext_16":"研究院已经申请的专利达到了3500多项，其国外专利1500多项；3777金沙娱场城药每年申请药学专利总量，化合物专利数量，化合物PCT专利，专利申报增长速度及专利质量均居中国前列水平。
\n"}">
